» Authors » Guillem Casas

Guillem Casas

Explore the profile of Guillem Casas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 200
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Casas G, Rodenas-Alesina E, Limeres J, Badia-Molins C, Larranaga-Moreira J, Mirelis J, et al.
Rev Esp Cardiol (Engl Ed) . 2025 Feb; PMID: 39920987
Introduction And Objectives: Defining the probability of cardiomyopathy in individuals with excessive trabeculation of the left ventricle (ETLV) is an unmet clinical need. Our aims were: a) to describe the...
2.
Baron J, Bernabe G, Gonzalez-Ferez P, Garcia J, Casas G, Gonzalez-Carrillo J
J Clin Med . 2025 Jan; 14(1. PMID: 39797353
Accurate segmentation of the left ventricular myocardium in cardiac MRI is essential for developing reliable deep learning models to diagnose left ventricular non-compaction cardiomyopathy (LVNC). This work focuses on improving...
3.
Rodenas-Alesina E, Lozano-Torres J, Tobias-Castillo P, Badia-Molins C, Vila-Olives R, Calvo-Barcelo M, et al.
Eur Heart J Imaging Methods Pract . 2024 Sep; 2(1):qyae063. PMID: 39224100
Aims: Atrial fibrillation (AF) is a common comorbidity in non-ischaemic dilated cardiomyopathy (NIDCM) affecting conventional measures of left atrial (LA) function. We aimed to determine whether LA function analysis could...
4.
Dux-Santoy L, Ruiz-Munoz A, Guala A, Galian-Gay L, Fernandez-Galera R, Valente F, et al.
J Cardiovasc Magn Reson . 2024 Aug; 26(2):101088. PMID: 39214465
Background: Patients with syndromic heritable thoracic aortic diseases (sHTAD) who underwent prophylactic aortic root replacement are at high risk of distal aortic events, but the underlying mechanisms remain unclear. This...
5.
Solsona-Caravaca J, Fernandez-Galera R, Gonzalez-Fernandez V, Airale L, Rivas J, Scudeler L, et al.
Biomedicines . 2024 Aug; 12(8). PMID: 39200177
Background: Longitudinal data on reverse cardiac remodeling and outcomes after transcatheter edge-to-edge repair (TEER) are limited. Methods: A total of 78 patients with severe mitral regurgitation (MR) were included retrospectively....
6.
Sempere A, Salvador F, Mila L, Casas G, Dura-Miralles X, Sulleiro E, et al.
PLoS Negl Trop Dis . 2024 Aug; 18(8):e0012410. PMID: 39102438
Background: Hypereosinophilic syndrome can produce cardiac involvement and endomyocardial fibrosis, which have a poor prognosis. However, there is limited information regarding cardiac involvement among migrants from Latin America with eosinophilia...
7.
Cesareo M, Rodenas-Alesina E, Guala A, Lozano-Torres J, Casas G, Vallelonga F, et al.
J Clin Med . 2024 Jul; 13(13). PMID: 38999432
: Non-ischemic dilated cardiomyopathy (NIDCM) is characterized by a reduced left ventricular (LV) ejection fraction (LVEF, <50%) and a high risk for heart failure (HF) and death. Echocardiography-derived hemodynamic forces...
8.
Dux-Santoy L, Rodriguez-Palomares J, Teixido-Tura G, Garrido-Oliver J, Carrasco-Poves A, Morales-Galan A, et al.
J Cardiovasc Magn Reson . 2024 Jan; 26(1):100992. PMID: 38211655
Background: The measurement of aortic dimensions and their evolution are key in the management of patients with aortic diseases. Manual assessment, the current guideline-recommended method and clinical standard, is subjective,...
9.
Baron J, Bernabe G, Gonzalez-Ferez P, Garcia J, Casas G, Gonzalez-Carrillo J
J Clin Med . 2023 Dec; 12(24). PMID: 38137702
Accurate diagnosis of Left Ventricular Noncompaction Cardiomyopathy (LVNC) is critical for proper patient treatment but remains challenging. This work improves LVNC detection by improving left ventricle segmentation in cardiac MR...
10.
de Frutos F, Ochoa J, Fernandez A, Gallego-Delgado M, Navarro-Penalver M, Casas G, et al.
Eur Heart J Cardiovasc Imaging . 2023 Aug; 25(1):75-85. PMID: 37562008
Aims: Late gadolinium enhancement (LGE) is frequently found in patients with dilated cardiomyopathy (DCM); there is little information about its frequency and distribution pattern according to the underlying genetic substrate....